Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), and as the disease progresses SHPT is associated with systemic consequences, termed CKD-mineral and bone disorder. Currently, cinacalcet is indicated for the treatment of SHPT; however, cinacalcet is assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Keitaro, Shimazaki, Ryutaro, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478860/
https://www.ncbi.nlm.nih.gov/pubmed/31015494
http://dx.doi.org/10.1038/s41598-019-42017-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478860/
https://www.ncbi.nlm.nih.gov/pubmed/31015494
http://dx.doi.org/10.1038/s41598-019-42017-z

Ejemplares similares